Cargando…

Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing

There have been few in vivo studies on the effect of aluminum hydroxide adjuvant and its influence on the immune response to vaccination. In this study, lambs received a parallel subcutaneous treatment with either commercial vaccines containing aluminum hydroxide or an equivalent dose of this compou...

Descripción completa

Detalles Bibliográficos
Autores principales: Varela-Martínez, Endika, Abendaño, Naiara, Asín, Javier, Sistiaga-Poveda, Maialen, Pérez, Marta Maria, Reina, Ramsés, de Andrés, Damián, Luján, Lluís, Jugo, Begoña M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206264/
https://www.ncbi.nlm.nih.gov/pubmed/30405610
http://dx.doi.org/10.3389/fimmu.2018.02406
_version_ 1783366337338277888
author Varela-Martínez, Endika
Abendaño, Naiara
Asín, Javier
Sistiaga-Poveda, Maialen
Pérez, Marta Maria
Reina, Ramsés
de Andrés, Damián
Luján, Lluís
Jugo, Begoña M.
author_facet Varela-Martínez, Endika
Abendaño, Naiara
Asín, Javier
Sistiaga-Poveda, Maialen
Pérez, Marta Maria
Reina, Ramsés
de Andrés, Damián
Luján, Lluís
Jugo, Begoña M.
author_sort Varela-Martínez, Endika
collection PubMed
description There have been few in vivo studies on the effect of aluminum hydroxide adjuvant and its influence on the immune response to vaccination. In this study, lambs received a parallel subcutaneous treatment with either commercial vaccines containing aluminum hydroxide or an equivalent dose of this compound only with the aim of identifying the activated molecular signature. Blood samples were taken from each animal at the beginning and at the end of the experiment and PBMCs isolated. Total RNA and miRNA libraries were prepared and sequenced. After alignment to the Oar3.1 reference genome and differential expression with 3 programs, gene enrichment modeling was performed. For miRNAs, miRBase and RNAcentral databases were used for detection and characterization. Three expression comparisons were made: vaccinated animals at the beginning and at the end of the treatment, adjuvanted animals at the same times, and animals of both treatments at the end of the experiment. After exposure to both treatments, a total of 2,473; 2,980 and 429 differentially expressed genes were identified in vaccinated animals, adjuvanted animals and animals at the end of both treatments, respectively. In both adjuvant and vaccine treated animals the NF-κB signaling pathway was enriched. On the other hand, it can be observed a downregulation of cytokines and cytokine receptors in the adjuvanted group compared to the vaccinated group at the final time, suggesting a milder induction of the immune response when the adjuvant is alone. As for the miRNA analysis, 95 miRNAs were detected: 64 previously annotated in Ovis aries, 11 annotated in Bos taurus and 20 newly described. Interestingly, 6 miRNAs were differentially expressed in adjuvant treated animals, and 3 and 1 in the other two comparisons. Lastly, an integrated miRNA-mRNA expression profile was developed, in which a miRNA-mediated regulation of genes related to DNA damage stimulus was observed. In brief, it seems that aluminum-containing adjuvants are not simple delivery vehicles for antigens, but also induce endogenous danger signals that can stimulate the immune system. Whether this contributes to long-lasting immune activation or to the overstimulation of the immune system remains to be elucidated.
format Online
Article
Text
id pubmed-6206264
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62062642018-11-07 Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing Varela-Martínez, Endika Abendaño, Naiara Asín, Javier Sistiaga-Poveda, Maialen Pérez, Marta Maria Reina, Ramsés de Andrés, Damián Luján, Lluís Jugo, Begoña M. Front Immunol Immunology There have been few in vivo studies on the effect of aluminum hydroxide adjuvant and its influence on the immune response to vaccination. In this study, lambs received a parallel subcutaneous treatment with either commercial vaccines containing aluminum hydroxide or an equivalent dose of this compound only with the aim of identifying the activated molecular signature. Blood samples were taken from each animal at the beginning and at the end of the experiment and PBMCs isolated. Total RNA and miRNA libraries were prepared and sequenced. After alignment to the Oar3.1 reference genome and differential expression with 3 programs, gene enrichment modeling was performed. For miRNAs, miRBase and RNAcentral databases were used for detection and characterization. Three expression comparisons were made: vaccinated animals at the beginning and at the end of the treatment, adjuvanted animals at the same times, and animals of both treatments at the end of the experiment. After exposure to both treatments, a total of 2,473; 2,980 and 429 differentially expressed genes were identified in vaccinated animals, adjuvanted animals and animals at the end of both treatments, respectively. In both adjuvant and vaccine treated animals the NF-κB signaling pathway was enriched. On the other hand, it can be observed a downregulation of cytokines and cytokine receptors in the adjuvanted group compared to the vaccinated group at the final time, suggesting a milder induction of the immune response when the adjuvant is alone. As for the miRNA analysis, 95 miRNAs were detected: 64 previously annotated in Ovis aries, 11 annotated in Bos taurus and 20 newly described. Interestingly, 6 miRNAs were differentially expressed in adjuvant treated animals, and 3 and 1 in the other two comparisons. Lastly, an integrated miRNA-mRNA expression profile was developed, in which a miRNA-mediated regulation of genes related to DNA damage stimulus was observed. In brief, it seems that aluminum-containing adjuvants are not simple delivery vehicles for antigens, but also induce endogenous danger signals that can stimulate the immune system. Whether this contributes to long-lasting immune activation or to the overstimulation of the immune system remains to be elucidated. Frontiers Media S.A. 2018-10-23 /pmc/articles/PMC6206264/ /pubmed/30405610 http://dx.doi.org/10.3389/fimmu.2018.02406 Text en Copyright © 2018 Varela-Martínez, Abendaño, Asín, Sistiaga-Poveda, Pérez, Reina, de Andrés, Luján and Jugo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Varela-Martínez, Endika
Abendaño, Naiara
Asín, Javier
Sistiaga-Poveda, Maialen
Pérez, Marta Maria
Reina, Ramsés
de Andrés, Damián
Luján, Lluís
Jugo, Begoña M.
Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing
title Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing
title_full Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing
title_fullStr Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing
title_full_unstemmed Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing
title_short Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing
title_sort molecular signature of aluminum hydroxide adjuvant in ovine pbmcs by integrated mrna and microrna transcriptome sequencing
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206264/
https://www.ncbi.nlm.nih.gov/pubmed/30405610
http://dx.doi.org/10.3389/fimmu.2018.02406
work_keys_str_mv AT varelamartinezendika molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing
AT abendanonaiara molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing
AT asinjavier molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing
AT sistiagapovedamaialen molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing
AT perezmartamaria molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing
AT reinaramses molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing
AT deandresdamian molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing
AT lujanlluis molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing
AT jugobegonam molecularsignatureofaluminumhydroxideadjuvantinovinepbmcsbyintegratedmrnaandmicrornatranscriptomesequencing